Investigators designed an online, tailored mindfulness-based cognitive therapy (MBCT) program for people with multiple sclerosis. The intervention will be delivered live via secure videoconferencing in groups of up to 15 participants. Each cohort receives weekly 2.5-hour sessions for eight weeks, with scheduled comfort breaks. Core practices include mindful-breath, mindful-body and mindful-movement awareness; sessions incorporate psychoeducation on depression, reflective group discussion (enquiry), and assigned home practice of up to 45 minutes per day. Trained MBCT instructors who have experience caring for PwMS will facilitate the groups. The source did not report specific instructor certification thresholds beyond these qualifications.
Adults aged 18 and older with neurologist-confirmed MS (McDonald criteria) are eligible if they score 14–28 on the BDI-II, indicating mild-to-moderate depression, can read and speak English, are registered with a primary care provider, and reside in Canada. Exclusion criteria include potentially life-threatening comorbidities (for example, active suicidal ideation per the BDI-FS suicidal question), history of psychosis, significant cognitive impairment (MoCA score <26), pregnancy or recent receipt of MBCT (at least four of eight sessions within the past two years). Recruitment materials will be distributed through MS organizations, the Canadian Network of MS Clinics, and social media. Interested individuals will complete eligibility screening by telephone or videoconference; consenting participants complete baseline questionnaires via REDCap.
Randomization will be computer-generated by a blinded biostatistician and implemented through REDCap. The trial uses a pragmatic waitlist-controlled design with cluster randomization in blocks: participants are randomized in clusters of 30 to immediate intervention or waitlist control in a 1:1 ratio. Investigators acknowledged challenges to participant blinding in mindfulness intervention trials and plan mitigation strategies: blinded assessors and statistician for analysis, allocation concealment by study ID, and participant instructions to avoid disclosing assignment to providers or assessors.
The primary outcome is change in depression measured continuously by the HADS-D (Hospital Anxiety and Depression Scale – Depression subscale). Assessments occur at baseline (T0), immediately post-intervention (T1, 8 weeks), and at follow-up (T2, 21 weeks) to evaluate both magnitude and short-term stability of effects. Investigators will also examine clinically meaningful reductions in HADS-D as an exploratory outcome, with a 20% reduction noted in the protocol as a minimally important difference (MID) used for exploratory comparisons. Secondary outcomes are listed in the protocol’s Table 1 and will be collected for exploratory analysis; the source text did not reproduce the full list within the manuscript summary provided here.
Implementation outcomes will be collected during the trial and formally assessed after 12 months. These outcomes follow the authors’ Table 2 taxonomy and will be mapped to RE-AIM dimensions (Reach, Effectiveness, Adoption, Implementation, Maintenance) informed by PRISM.
Investigators based the sample size on prior 3-month follow-up data from Bogosian et al., assuming a between-group difference of 2 HADS-D units with SD 3.5 (effect size ~0.57 SD). A minimum sample of 152 participants is planned to provide 80% power for linear regression models across three time points, with adjustments for intracluster correlation (assumed 0.2), baseline covariate correction (assumed 0.4), and 16% loss to follow-up. All statistical analyses will be performed by blinded staff and a detailed statistical analysis plan will be finalized before database lock.
Primary analyses will use linear mixed-effects models including fixed effects for group, time, and group-by-time interaction, with subjects clustered within MBCT groups as random effects to account for within-group dependencies. Secondary models will adjust for baseline demographic covariates selected via variable selection/shrinkage methods (the protocol specifies LASSO) and will assess multicollinearity and model fit. Exploratory subgroup analyses (age, sex, gender identity, ethnicity) are planned; the source did not provide pre-specified subgroup hypotheses beyond these categories.
A purposive subset of 30–40 MBCT participants will be invited for semi-structured interviews conducted by videoconference to explore motivations, acceptability, accessibility, perceived effects, and implementation barriers and facilitators. Health care professionals, MBCT instructors, and MS decision makers will also be interviewed. Interview data will be transcribed verbatim and analyzed using thematic methods. Investigators will integrate qualitative and quantitative findings using joint displays, mapping emergent themes onto RE-AIM/PRISM constructs to inform recommendations for tailoring and scaling the intervention.
Trial outcomes and socio-demographic data (age, sex, gender identity, race/ethnicity, living situation, income bracket, education, disease duration, disability level, comorbidities, DMT and psychotropic use) will be collected online via REDCap at T0, T1 and T2. The trial is registered on ClinicalTrials.Gov (NCT07742579) and will be run through the University of Toronto. Funders include the National MS Society/MS Canada RFA; the funder will not influence trial design or reporting, according to the authors. The source states that all relevant data will be made available after study completion.
The protocol acknowledges challenges with participant blinding intrinsic to MBCT trials and describes mitigation steps; it does not report outcome data or trial results. The source did not specify exact timelines for primary outcome reporting beyond the 21-week follow-up and 12-month implementation assessment. Outstanding questions that remain to be answered by the trial include the observed effectiveness of the tailored online MBCT on HADS-D in PwMS, the degree to which the intervention can be feasibly adopted across clinical settings in Canada, and which tailoring elements are most critical to sustain engagement and long-term practice. The study team plans dissemination through traditional and creative knowledge mobilization methods once data are available.